|
|||||
       |
Aerial photograph of MD Anderson campus in 2011 (MDAnderson.org) 7 October 2015. MD Anderson Cancer Center in Houston is partnering with the biotechnology company Theraclone Sciences to form a new enterprise devoted to discovering antibodies for cancer therapies harnessing the immune system. The company named OncoResponse, also based in Houston, attracted $9.5 million . . . → Read More: MD Anderson, Biotech Form Antibody Discovery Company  One comment - (Comments are closed)  Finance, Joint ventures/collaborations  biomedical, biotechnology, cancer, entrepreneurs, equity, investment, life sciences, medical device, pharmaceuticals, venture capital Atieh “Amy” Haghdoost, left, and Mehdi Kargar, founders of Maxterial Inc. (Breakout Labs) 6 October 2015. Breakout Labs, an incubator of new enterprises based on discoveries from academic science labs, is adding four more companies to its portfolio. The new additions include companies developing advanced materials and sensors to measure food freshness, as . . . → Read More: Breakout Labs Adds Four Science-Based Start-Ups Comments are closed Finance, Joint ventures/collaborations biomedical, chemistry, engineering, entrepreneurs, grant, life sciences, materials science, nanotechnology, physical sciences, university (Public Domain Pictures/Pixabay) 6 October 2015. DeNovo Sciences, a developer of liquid biopsies and analytics, is teaming with bioTheranostics, a cancer diagnostics company using molecular biomarkers, to test the feasibility of combining their technologies. Financial and intellectual property details of the collaboration were not disclosed. In testing for solid tumor cancers, such as . . . → Read More: Partnership to Study Biomarkers in Liquid Biopsies 2 comments - (Comments are closed) Joint ventures/collaborations biomarkers, biomedical, cancer, engineering, genomics, life sciences, medical device (nvtriab, Pixabay) 5 October 2015. An app made for the Apple iPhone now allows people with hepatitis C to record real-world data on their experiences with treatments and living with the disease. The C-Tracker app, developed by Boston Children’s Hospital, is available as a free download from the iPhone App Store. Hepatitis C . . . → Read More: iPhone App Capturing Hepatitis C Research Data Electron-microscope image of the 2009 H1N1 influenza virus (CDC.gov) 5 October 2015. A clinical trial testing a synthetic antibody designed to treat influenza A shows the treatment is effective in reducing the spread of flu viruses in humans. Visterra Inc., the therapy’s designer, also received a contract valued as much as $204.5 million . . . → Read More: Influenza A Therapy Shown Working in Trial Comments are closed Finance, Regulations biomedical, biotechnology, clinical trials, contract, entrepreneurs, life sciences, pharmaceuticals, university Carbonate particle releasing carbon dioxide and moving at high speed (James Baylis, University of British Columbia) 2 October 2015. A biochemistry lab designed microscale particles that travel on their own through the body to stop heavy bleeding in trauma victims, surgery, and childbirth. Researchers at University of British Columbia in Vancouver, Canada led . . . → Read More: Self-Propelled Particles Designed to Stop Bleeding Comments are closed New products biomedical, Canada, chemistry, engineering, life sciences, materials science, medical device, pharmaceuticals, physical sciences, university (U.S. Air Force) 2 October 2015. Materials scientists and chemists designed a polymer additive that reduces the explosive nature of jet fuel in crashes or terror attacks, without compromising the fuel’s performance. Researchers from California Institute of Technology and Jet Propulsion Laboratory in Pasadena published their findings in today’s issue of the journal . . . → Read More: Jet Fuel Additive Reduces Chance for Crash Explosions Comments are closed New products chemistry, energy, engineering, materials science, physical sciences, physics, university (bfishadow, WikimediaCommons) 1 October 2015. A biotechnology company developing therapies based on RNA, genetic material that sends signals to cells, raised $43.75 million in its initial public stock offering. Mirna Therapeutics Inc. in Austin, Texas issued 6.25 million shares today at $7.00, and trades on the Nasdaq exchange under the symbol MIRN. Its . . . → Read More: RNA Therapy Biotech Earns $44 Million in IPO Comments are closed Finance biomedical, biotechnology, cancer, clinical trials, equity, investment, IPO, life sciences, pharmaceuticals, preclinical Cornell dots illuminate cells in a lab mouse, in a 2009 preclinical study. (Memorial Sloan Kettering Cancer Center) 1 October 2015. Cornell University and Memorial Sloan Kettering Cancer Center are developing cancer diagnostics and therapies with nanoscale particles, funded largely by a National Cancer Institute grant. NCI, part of National Institutes of Health, . . . → Read More: Nanotech Cancer Center Gains $10.1M Funding One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, cancer, clinical trials, engineering, entrepreneurs, grant, life sciences, materials science, medical device, nanotechnology, NIH, patent, pharmaceuticals, physical sciences, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.